Company reports US$522K in July sales, US$403K in August sales, and US$2.07M in sales for the first eight months of 2026, surpassing US$1.8M in total sales for 2025
Toronto, Ontario -
Newsfile Corp. - September 18, 2026 - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (OTCQB: TMPTF) ("
TempraMed" or the "
Company"), a medical-technology...
Read more: TempraMed Reports Record July Sales and Strong August Performance, with Year-to-Date Sales Already...